Autoantibodies to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies
Steven Vernino, M.D., Ph.D., Phillip A. Low, M.D., Robert D. Fealey, M.D., John D. Stewart, M.B., B.S., Gianrico Farrugia, M.D., and Vanda A. Lennon, M.D., Ph.D.
Background Idiopathic autonomic neuropathy is a severe, subacutedisorder with a presumed autoimmune basis. It is indistinguishablefrom the subacute autonomic neuropathy that may accompany lungcancer or other tumors. Autoantibodies specific for nicotinicacetylcholine receptors in the autonomic ganglia are potentiallypathogenic and may serve as serologic markers of various formsof autoimmune autonomic neuropathy.
Methods We tested serum from 157 patients with a variety oftypes of dysautonomia. Immunoprecipitation assays with iodine-125labeledepibatidine and solubilized human neuroblastoma acetylcholinereceptors were used to detect autoantibodies that bound to orblocked ganglionic receptors.
Results Ganglionic-receptorbinding antibodies were foundin 19 of 46 patients with idiopathic or paraneoplastic autonomicneuropathy (41 percent), in 6 of 67 patients with postural tachycardiasyndrome, idiopathic gastrointestinal dysmotility, or diabeticautonomic neuropathy (9 percent), and in none of 44 patientswith other autonomic disorders. High levels of the binding antibodiescorrelated with more severe autonomic dysfunction (includingthe presence of tonic pupils). Levels of these antibodies decreasedin patients who had clinical improvement. All seven patientswith ganglionic-receptorblocking antibodies had ganglionic-receptorbindingantibodies and had idiopathic or paraneoplastic autonomic neuropathy.
Conclusions Seropositivity for antibodies that bind to or blockganglionic acetylcholine receptors identifies patients withvarious forms of autoimmune autonomic neuropathy and distinguishesthese disorders from other types of dysautonomia. The positivecorrelation between high levels of ganglionic-receptor antibodiesand the severity of autonomic dysfunction suggests that theantibodies have a pathogenic role in these types of neuropathy.
Source Information
From the Departments of Neurology (S.V., P.A.L., R.D.F., V.A.L.), Immunology (V.A.L.), and Laboratory Medicine and Pathology (V.A.L.) and the Division of Gastroenterology and Hepatology (G.F.), Mayo Clinic, Rochester, Minn.; and the Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal (J.D.S.).
Address reprint requests to Dr. Vernino at the Department of Neurology, Mayo Clinic, 200 First St., S.W., Rochester, MN 55905, or at verns{at}mayo.edu.
Gibbons, C. H., Vernino, S. A., Freeman, R.
(2008). Combined Immunomodulatory Therapy in Autoimmune Autonomic Ganglionopathy. Arch Neurol
65: 213-217
[Abstract][Full Text]
Benarroch, E. E.
(2007). Enteric nervous system: Functional organization and neurologic implications. Neurology
69: 1953-1957
[Full Text]
Garland, E. M., Black, B. K., Harris, P. A., Robertson, D.
(2007). Dopamine-beta-hydroxylase in postural tachycardia syndrome. Am. J. Physiol. Heart Circ. Physiol.
293: H684-H690
[Abstract][Full Text]
Lipp, A., Sandroni, P., Ahlskog, J. E., Maraganore, D. M., Shults, C. W., Low, P. A.
(2007). Calf venous compliance in multiple system atrophy. Am. J. Physiol. Heart Circ. Physiol.
293: H260-H265
[Abstract][Full Text]
BLAES, F., TSCHERNATSCH, M., BRAEU, M. E., MATZ, O., SCHMITZ, K., NASCIMENTO, D., KAPS, M., BIRKLEIN, F.
(2007). Autoimmunity in Complex-Regional Pain Syndrome. Ann. N. Y. Acad. Sci.
1107: 168-173
[Abstract][Full Text]
Wang, Z., Low, P. A., Jordan, J., Freeman, R., Gibbons, C. H., Schroeder, C., Sandroni, P., Vernino, S.
(2007). Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology
68: 1917-1921
[Abstract][Full Text]
Modoni, A., Mirabella, M., Madia, F., Sanna, T., Lanza, G., Tonali, P. A., Silvestri, G.
(2007). Chronic autoimmune autonomic neuropathy responsive to immunosuppressive therapy. Neurology
68: 161-162
[Full Text]
Brooks, J. K., Francis, L. A.P.
(2006). Postural orthostatic tachycardia syndrome: Dental treatment considerations. Journal of the American Dental Association
137: 488-493
[Abstract][Full Text]
Jacob, G., Garland, E. M., Costa, F., Stein, C. M., Xie, H.-G., Robertson, R. M., Biaggioni, I., Robertson, D.
(2006). {beta}2-Adrenoceptor Genotype and Function Affect Hemodynamic Profile Heterogeneity in Postural Tachycardia Syndrome. Hypertension
47: 421-427
[Abstract][Full Text]
Stewart, J. M., Medow, M. S., Glover, J. L., Montgomery, L. D.
(2006). Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome. Am. J. Physiol. Heart Circ. Physiol.
290: H665-H673
[Abstract][Full Text]
Garland, E. M., Winker, R., Williams, S. M., Jiang, L., Stanton, K., Byrne, D. W., Biaggioni, I., Cascorbi, I., Phillips, J. A. III, Harris, P. A., Rudiger, H., Robertson, D.
(2005). Endothelial NO Synthase Polymorphisms and Postural Tachycardia Syndrome. Hypertension
46: 1103-1110
[Abstract][Full Text]
Schroeder, C., Vernino, S., Birkenfeld, A. L., Tank, J., Heusser, K., Lipp, A., Benter, T., Lindschau, C., Kettritz, R., Luft, F. C., Jordan, J.
(2005). Plasma exchange for primary autoimmune autonomic failure.. NEJM
353: 1585-1590
[Abstract][Full Text]
Pleasure, D.
(2005). Keeping "Trk" of Paraneoplastic Syndromes. Arch Neurol
62: 1508-1509
[Full Text]
Vinik, A. I., Anandacoomaraswamy, D., Ullal, J.
(2005). Antibodies to Neuronal Structures: Innocent bystanders or neurotoxins?. Diabetes Care
28: 2067-2072
[Full Text]
Levine, J. M., Bergman, R. L., Coates, J. R., Shelton, G. D.
(2005). Myasthenia Gravis and Hypothyroidism in a Dog With Meningomyelitis. Journal of the American Animal Hospital Association
41: 247-251
[Abstract][Full Text]
Mittermayer, F., Schaller, G., Pleiner, J., Vychytil, A., Sunder-Plassmann, G., Horl, W. H., Wolzt, M.
(2005). Asymmetrical Dimethylarginine Plasma Concentrations Are Related to Basal Nitric Oxide Release but Not Endothelium-Dependent Vasodilation of Resistance Arteries in Peritoneal Dialysis Patients. J. Am. Soc. Nephrol.
16: 1832-1838
[Abstract][Full Text]
Shibao, C., Gamboa, A., Diedrich, A., Biaggioni, I.
(2005). Management of Hypertension in the Setting of Autonomic Failure: A Pathophysiological Approach. Hypertension
45: 469-476
[Abstract][Full Text]
Vernino, S., Lennon, V. A.
(2004). Autoantibody Profiles and Neurological Correlations of Thymoma. Clin. Cancer Res.
10: 7270-7275
[Abstract][Full Text]
Vernino, S., Ermilov, L. G., Sha, L., Szurszewski, J. H., Low, P. A., Lennon, V. A.
(2004). Passive Transfer of Autoimmune Autonomic Neuropathy to Mice. J. Neurosci.
24: 7037-7042
[Abstract][Full Text]
Thieben, M. J., Lennon, V. A., Boeve, B. F., Aksamit, A. J., Keegan, M., Vernino, S.
(2004). Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology
62: 1177-1182
[Abstract][Full Text]
Singer, W., Spies, J. M., McArthur, J., Low, J., Griffin, J. W., Nickander, K. K., Gordon, V., Low, P. A.
(2004). Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology
62: 612-618
[Abstract][Full Text]
Sandroni, P., Vernino, S., Klein, C. M., Lennon, V. A., Benrud-Larson, L., Sletten, D., Low, P. A.
(2004). Idiopathic Autonomic Neuropathy: Comparison of Cases Seropositive and Seronegative for Ganglionic Acetylcholine Receptor Antibody. Arch Neurol
61: 44-48
[Abstract][Full Text]
Lang, P. M., Burgstahler, R., Sippel, W., Irnich, D., Schlotter-Weigel, B., Grafe, P.
(2003). Characterization of Neuronal Nicotinic Acetylcholine Receptors in the Membrane of Unmyelinated Human C-Fiber Axons by In Vitro Studies. J. Neurophysiol.
90: 3295-3303
[Abstract][Full Text]
Biaggioni, I.
(2003). Autoimmune Ganglionic Blockade. A Cause of Autonomic Failure. Focus on "Experimental Autoimmune Autonomic Neuropathy". J. Neurophysiol.
90: 1377-1378
[Full Text]
LINDSTROM, J. M.
(2003). Nicotinic Acetylcholine Receptors of Muscles and Nerves: Comparison of Their Structures, Functional Roles, and Vulnerability to Pathology. Ann. N. Y. Acad. Sci.
998: 41-52
[Abstract][Full Text]
VERNINO, S., LENNON, V. A.
(2003). Neuronal Ganglionic Acetylcholine Receptor Autoimmunity. Ann. N. Y. Acad. Sci.
998: 211-214
[Abstract][Full Text]
Vernino, S., Low, P. A., Lennon, V. A.
(2003). Experimental Autoimmune Autonomic Neuropathy. J. Neurophysiol.
90: 2053-2059
[Abstract][Full Text]
Yusuf, S., Camm, A. J.
(2003). Sinus Tachyarrhythmias and the Specific Bradycardic Agents: A Marriage Made in Heaven?. J CARDIOVASC PHARMACOL THER
8: 89-105
[Abstract]
Moses, P L, Ellis, L M, Anees, M R, Ho, W, Rothstein, R I, Meddings, J B, Sharkey, K A, Mawe, G M
(2003). Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut
52: 629-636
[Abstract][Full Text]
Wang, N., Orr-Urtreger, A., Chapman, J., Rabinowitz, R., Korczyn, A. D.
(2003). Deficiency of Nicotinic Acetylcholine Receptor beta 4 Subunit Causes Autonomic Cardiac and Intestinal Dysfunction. Mol. Pharmacol.
63: 574-580
[Abstract][Full Text]
GARLAND, E. M., HAHN, M. K., KETCH, T. P., KELLER, N. R., KIM, C.-H., KIM, K.-S., BIAGGIONI, I., SHANNON, J. R., BLAKELY, R. D., ROBERTSON, D.
(2002). Genetic Basis of Clinical Catecholamine Disorders. Ann. N. Y. Acad. Sci.
971: 506-514
[Abstract][Full Text]
Bloomgarden, Z. T.
(2002). Neuropathy, Womens' Health, and Socioeconomic Aspects of Diabetes. Diabetes Care
25: 1085-1094
[Full Text]
Guyton, G. P., Saltzman, C. L.
(2001). The Diabetic Foot : Basic Mechanisms of Disease. JBJS
83: 1083-1096
[Full Text]